Credit: Courtesy of St. Jude Children's Research Hospital
Corresponding author Jun Yang, MD, PhD, (left) and co-first authors Jie Fang, PhD, (center) and Shivendra Singh, PhD (right), identified a window of opportunity to treat high-risk MYCN-amplified neuroblastoma.